Jack Henry Danon

Jack Henry Danon is an attorney at Williams & Connolly LLP, focusing his practice on civil litigation and trial matters. The firm's patent litigation practice is particularly known for representing brand-name pharmaceutical companies in Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) disputes against generic and biosimilar challengers, as well as handling high-stakes patent and intellectual property disputes for major technology and biotechnology companies.

His tracked experience indicates a preference for defendant-side work, aligning with Williams & Connolly's strong track record in defending market exclusivity for its clients. While specific notable cases for Mr. Danon are not detailed, the firm has achieved significant successes for pharmaceutical clients in patent disputes at trial and in the Federal Circuit, including representing Pfizer in COVID-19 vaccine litigation.

Williams & Connolly's intellectual property group also has extensive experience with inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB), having handled over 100 IPRs concurrent with district court proceedings.

Mr. Danon earned his J.D. from the University of Virginia School of Law in 2021 and his B.A. from the University of Pennsylvania in 2016. He is admitted to practice in the District of Columbia and Florida and previously served as a law clerk to Chief Judge Cecilia M. Altonaga of the United States District Court for the Southern District of Florida from 2022–2023.